These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9739019

  • 1. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.
    Levati L, Marra G, Lettieri T, D'Atri S, Vernole P, Tentori L, Lacal PM, Pagani E, Bonmassar E, Jiricny J, Graziani G.
    Genes Chromosomes Cancer; 1998 Oct; 23(2):159-66. PubMed ID: 9739019
    [Abstract] [Full Text] [Related]

  • 2. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.
    Umar A, Koi M, Risinger JI, Glaab WE, Tindall KR, Kolodner RD, Boland CR, Barrett JC, Kunkel TA.
    Cancer Res; 1997 Sep 15; 57(18):3949-55. PubMed ID: 9307278
    [Abstract] [Full Text] [Related]

  • 3. XPC lymphoblastoid cells defective in the hMutSalpha DNA mismatch repair complex exhibit normal sensitivity to UVC radiation and normal transcription-coupled excision repair of DNA cyclobutane pyrimidine dimers.
    Kobayashi K, O'Driscoll M, Macpherson P, Mullenders L, Vreeswijk M, Karran P.
    DNA Repair (Amst); 2004 Jun 03; 3(6):649-57. PubMed ID: 15135732
    [Abstract] [Full Text] [Related]

  • 4. Degadration of mismatch repair hMutSalpha heterodimer by the ubiquitin-proteasome pathway.
    Hernandez-Pigeon H, Laurent G, Humbert O, Salles B, Lautier D.
    FEBS Lett; 2004 Mar 26; 562(1-3):40-4. PubMed ID: 15043999
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells.
    Szadkowski M, Iaccarino I, Heinimann K, Marra G, Jiricny J.
    Cancer Res; 2005 Jun 01; 65(11):4525-9. PubMed ID: 15930269
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.
    Kohya N, Kitajima Y, Kitahara K, Miyazaki K.
    Int J Mol Med; 2003 Jan 01; 11(1):65-9. PubMed ID: 12469220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE, Davis TW, Schupp JE, Hwang HS, de Wind N, Kinsella TJ.
    Cancer Res; 2000 Oct 15; 60(20):5773-80. PubMed ID: 11059773
    [Abstract] [Full Text] [Related]

  • 11. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K, Zhong X, Kanazawa S, Koike J, Tsujita K, Hemmi H.
    Oncol Rep; 2003 Oct 15; 10(4):859-66. PubMed ID: 12792735
    [Abstract] [Full Text] [Related]

  • 12. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
    Branch P, Hampson R, Karran P.
    Cancer Res; 1995 Jun 01; 55(11):2304-9. PubMed ID: 7757980
    [Abstract] [Full Text] [Related]

  • 13. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
    Claij N, Te Riele H.
    Oncogene; 2002 Apr 25; 21(18):2873-9. PubMed ID: 11973647
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
    Ochs K, Kaina B.
    Cancer Res; 2000 Oct 15; 60(20):5815-24. PubMed ID: 11059778
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.
    Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S, Graziani G.
    Mol Pharmacol; 1997 Aug 15; 52(2):249-58. PubMed ID: 9271347
    [Abstract] [Full Text] [Related]

  • 16. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O, Fiumicino S, Aquilina G, Branch P, Oda S, Zijno A, Karran P, Bignami M.
    Carcinogenesis; 1999 Feb 15; 20(2):205-14. PubMed ID: 10069455
    [Abstract] [Full Text] [Related]

  • 17. hMSH2 and hMSH6 play distinct roles in mismatch binding and contribute differently to the ATPase activity of hMutSalpha.
    Iaccarino I, Marra G, Palombo F, Jiricny J.
    EMBO J; 1998 May 01; 17(9):2677-86. PubMed ID: 9564049
    [Abstract] [Full Text] [Related]

  • 18. Mismatch recognition and DNA-dependent stimulation of the ATPase activity of hMutSalpha is abolished by a single mutation in the hMSH6 subunit.
    Dufner P, Marra G, Räschle M, Jiricny J.
    J Biol Chem; 2000 Nov 24; 275(47):36550-5. PubMed ID: 10938287
    [Abstract] [Full Text] [Related]

  • 19. Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor.
    Glaab WE, Risinger JI, Umar A, Kunkel TA, Barrett JC, Tindall KR.
    J Biol Chem; 1998 Oct 09; 273(41):26662-9. PubMed ID: 9756907
    [Abstract] [Full Text] [Related]

  • 20. A mutation in the MSH5 gene results in alkylation tolerance.
    Bawa S, Xiao W.
    Cancer Res; 1997 Jul 01; 57(13):2715-20. PubMed ID: 9205082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.